AUG/SEPT 16: ISSUE 117

Page 9 - THE CASE FOR HEALTH-GAIN AND BODY RESPECT IN HEALTHY WEIGHT SERVICES

1 Bacon L and Aphramor L (2011). Weight Science: Evaluating the evidence for a paradigm shift. Nutrition Journal, 10 (9), viewed on 20 March 2016 from https://nutritionj.biomedcentral.com/articles/10.1186/1475-2891-10-9

2 Marmot M (2004). Status syndrome: How your social standing directly affects your health. Bloomsbury, UK

3 Chandola T, Brunner E and Marmot M (2006). Chronic stress at work and the metabolic syndrome: prospective study. British Medical Journal, 332:521, viewed 23 March 2016 at www.bmj.com/content/332/7540/521.long

4 Pickett K and Wilkinson R. (2010). The spirit level: Why equality is better for everyone. Penguin, UK

5 Raphael D, Lines E, Bryant T, Daiski I, Pilkington B, Dinca-Panaitescu S and Dinca-Panaitescu M (2010). Type 2 Diabetes: poverty, priorities and policy: the social determinants of the incidence and management of Type 2 diabetes, Toronto. York University School of Health Policy and Management and School of Nursing

6 Aphramor L (2005). Is a weight-centred health framework salutogenic? Some thoughts on unhinging certain dietary ideologies. Social Theory and Health, 3 (4), 315-340

7 Scottish Intercollegiate Guidelines Network (SIGN), Management of Obesity, Guideline No 115. Edinburgh, February 2010, p 18

8 British Nutrition Foundation. Obesity: The Report of the British Nutrition Foundation Task Force. Blackwell Science: London, 1999, p 137

9 Mann T et al. Medicare’s search for effective obesity treatments: Diets are not the answer. American Psychologist, Vol 62, 2007, pp 220-233

10 NICE guidelines [PH53] (2014). Weight management: lifestyle services for overweight or obese adults. National Institute for Health and Care Excellence, London. May 2014

11 Aphramor L (2010) Validity of claims in weight management: a review of dietetic literature. Nutrition Journal, 9, 30, viewed on 20 March 2016 from https://nutritionj.biomedcentral.com/articles/10.1186/1475-2891-9-30

12 Howard BV et al. Low-fat dietary pattern and weight change over 7 years: the Women’s Health Initiative Dietary Modification Trial. Journal of the American Medical Association, Vol 295, 2006, pp 39-49

13 Aphramor L and Khasteganan N. How do people with eating and weight concerns experience dietetic discourses of compassion and control? Presentation at International Critical Dietetics Conference, Sydney Law School, 1 September 2012, Australia

14 Aphramor L and Khasteganan N. Reorienting Interventions for Nutritional Wellbeing: A Qualitative Study’; under review, Journal of Critical Dietetics

15 Gilbert P. The Compassionate Mind, 2009, Constable, London

16 Aphramor L. Mindfulness in Healthy Weight and Diabetes. Journal of Diabetes Nursing, Vol 19, 2015, pp 410-407

17 Clarke F, MacDonald V and Huc S. What next for Well Now? A group based Weight Management intervention which prioritises health gain over weight loss. Presented at NHS Highland: Research, Development and Innovation Annual conference, 13 November 2015, University of the Highlands and Islands, Inverness

Page 15 - NUTRITIONAL MANAGEMENT OF THE BARIATRIC PATIENT

1 The Health and Social Care Information Centre 2015. Health Survey for England 2014. Chapter 9. Adult Obesity and Overweight p 1-17. www.hscic.gov.uk/catalogue/PUB19295/HSE2014-ch9-adult-obe.pdf (Accessed June 2016)

2 NICE (2014). National Institute for Health and Care Excellence. Obesity: identification, assessment and management. CG189. November 2014. www.nice.org.uk/guidance/cg189/chapter/1-recommendations#surgical-interventions (Accessed June 2016)

3 National Obesity Observatory (NOO). Bariatric Surgery for Obesity. August 2010. www.noo.org.uk/uploads/doc/vid_8774_NOO%20Bariatric%20Surgery%20for%20Obesity%20FINAL%20MG%20011210.pdf (Accessed June 2016)

4 Nguyen D et al. Outcomes of revisional treatment modalities in non-complicated Roux En Y Gastric Bypass patients with weight regain. Obesity Surgery; 25(5): 928-934

5 Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high risk super obese patients. Obes Surg 2004; 14: 492-7

6 Picot J, Jones J, Colquitt JL et al. The clinical effectiveness and cost effectiveness of bariatric (weight loss) surgery for obesity. A systematic review and economic evaluation. Health Technology Assessment 2009, 13 (41)

7 Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sulllivan M, Wedel H. Swedish Obese Subjects Study Scientific Group. 2004. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693

8 Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003). Effect of laparoscopic Roux en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238: 467-484; discussion 84-85

9 Dixon JB, O Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M (2008). Adjustable gastric banding and conventional therapy for Type 2 diabetes: a randomised controlled trial. JAMA 299:316-323

10 Heber D, Greenway FL, Kaplan LM, Livingstone E, Salvador J, Stilll C. Endocrine and Nutritional Management of the Post Bariatric Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2010). 95(11); 4823-4843

11 Lim SL, Lye J, Liang S, Miller M, Chong YS. Development and validation of an expedited 10g protein counter (EP-10) for dietary protein intake quantification. J Ren Nutr 2012; 22(6): 558-66. www.ncbi.nlm.nih.gov/pubmed/22226755 (Accessed June 2016)

12 Shikora SA, Kim JJ, Tarnoff ME (2007). Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract 22: 29-40

13 Brolin RE, LaMarca LB, Kenler HA, Cody RP (2002). Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 6:195-203

14 Cooper PL, Brearley LK, Jemieson AC, Ball MJ (1999). Nutritional consequences of modified vertical gastroplasty in obese subjects. Int J Obes Relat Metab Disord 23: 382-388

15 Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LB, Kenler HA, Cody RP (1998). Prophylactic iron supplementation after Roux en Y gastric bypass: a prospective, double blind randomised study. Arch Surg 133:740-744

16 Rhode BM, Shustik C, Chrisou NV, MacLean LD (1999) Iron absorption and therapy after gastric bypass. Obes Surgery 9:17-21

17 www.nwcr.ws (Accessed June 2016)

18 Greene LF et al. Weight Maintenance 2 years after participation in a weight loss program promoting low energy density foods. Obesity (Silver Spring Md). 2006; 14 (10): 1795 -1801

19 www.scotsurgerystudy.org.uk/Default.aspx?ReturnUrl=%2f (Accessed June 2016)

Page 21 - MAPLE SYRUP URINE DISEASE IN ADULTS - AN OVERVIEW

1 Ogier de Baulny H, Dionisi-Vici C and Wendel U (2012). Branched Chain Organic Acidurias/Acidaemias (277-296) in Saudubray JM, van den Berghe G and Walter JH: Inborn Metabolic Disease: Diagnosis and Treatment, 5th Ed, Springer, Berlin, Heidelburg

2 www.expandedscreening.org/site/home/metabolic-msud-facts.asp (accessed 2 July 2016)

3 Walterfang M, Bonnot O, Mocelline R and Velakoulis D (2013). The neuropsychiatry of inborn errors of metabolism

4 Klee D, Thimm E, Wittsack HJ et al (2013). Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis 36: 945-953

5 Le Roux C, Murply E, Hallam P et al (2006). Neuropsychometric outcome predictors with adults with maple syrup urine disease. J Inherit Metab Dis 29:201-202

6 Simon E, Schwarz M, Wendel U (2007). Social Outcomes in adults with maple syrup urine disease. J Inherit Metab Dis 30: 264

7 Frazier D et al (2014). Nutrition management guideline for maple syrup urine disease: an evidence and consensus based approach; Molecular Genetics and Metabolism 112; 210-217

8 Dixon M, MacDonald A, White F and Stafford J (2014). Disorders of Amino Acid Metabolism, Organic Acidaemias and Urea Cycle Disorders in Clinical Paediatric Dietetics; Ed Shaw V, 4th Ed, Wiley Blackwell, Oxford 381-525

9 Marriage B (2010). Nutrition management of patients with inherited disorders of Branched Chain Amino Acid metabolism. Acosta P Nutrition Management in Patients with Inherited Metabolic Disorders

10 Mazer LM, Yi SHL and Singh RH (2010). Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease; J Inherit Metab Dis 33:121-127

11 Strauss KA, Wardley B, Robinson D et al (2010). Classical maple syrup disease and brain development: Principles of management and formula design. Molecular Genetics and Metabolism 99: 333-345

12 Grader G, Haege G, Glahn EM et al (2014). Living with an inborn error of metabolism detected by newborn screening - Parents' perspectives on child development and impact on family life; J Inherit Metab Dis 37: 189-195

13 Stefanie Heiber, Henryk Zulewski, Marianne Zaugg, Caroline Kiss and Matthias Baumgartner (2015). Successful pregnancy in a woman with Maple Syrup Urine Disease: Case Report. JIMD Rep. 2015; 21: 103-107

14 Wessel AE, Mogensen KM, Rohr F, Erick M, Neilan EG, Chopra S, Levy HL, Gray KJ, Wilkins-Haug L, Berry GT (2015). Management of a woman with Maple Syrup Urine Disease during pregnancy, delivery and lactation. JPEN J Parenteral Enteral Nutr. 2015 Sep;39(7): 875-9. doi: 10.1177/0148607114526451. Epub 2014 Mar 11

Page 25 MALNUTRITION A MULTIDISCIPLINARY APPROACH

1. NHS England. Commissioning Excellent Nutrition and Hydration (2015-2018). www.england.nhs.uk/wp-content/uploads/2015/10/nut-hyd-guid.pdf

2. Elia M and Stratton RJ (2009). Calculating the cost of disease-related malnutrition in the UK in 2007 (public expenditure only) in: Combating Malnutrition. BAPEN. www.bapen.org.uk/pdfs/reports/advisory_group_report.pdf

3. Guest et al (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK www.ncbi.nlm.nih.gov/pubmed/21406315

4. National Institute for Clinical Excellence (NICE). Nutrition Support in Adults (32) Cost Saving Guidance (2011). http://publications.nice.org.uk/nutrition-support-in-adults-cg32/guidance

5. Brotherton et al (2012). Managing Adult Malnutrition in the Community http://malnutritionpathway.co.uk/downloads/Managing_Malnutrition.pdf

6. RCN. Principles of Nursing Practice. Accessed 2016 via: www.rcn.org.uk/professional-development/principles-of-nursing-practice

7. Sura et al (2012). Dysphagia in the elderly: management and nutritional considerations. www.ncbi.nlm.nih.gov/pmc/articles/PMC3426263/

8. Pereira et al (2014). Malnutrition among cognitively intact, non-critically ill older adults in the emergency department. Annals of Emergency Medicine, 65(1), 85-91

9. Yoshimura et al (2013). Relationship between depression and risk of malnutrition among community-dwelling young-old and old-old elderly people

Page 33 - SPECIALISED INFANT FORMULA: AN OVERVIEW

1 World Health Organisation (2003). Global Strategy for Infant and Child Feeding. Geneva: WHO. Available at: http://apps.who.int/iris/bitstream/10665/42590/1/9241562218.pdf?ua=1&ua=1 (accessed May 2016)

2 World Health Organisation (2009). Acceptable medical reasons for use of breast-milk substitutes. Geneva: WHO

3 First Steps Nutrition Trust (2016). Infant Milks in the UK: A Practical Guide for Health Professionals. Available at: www.firststepsnutrition.org/pdfs/Infant_Milks_February2016.pdf (accessed May 2016)

4 First Steps Nutrition Trust (2015). Specialised Infant Milks in the UK: Infants 0-6 months. Information for Health Professionals. Available at: www.firststepsnutrition.org/pdfs/Specialised_infant_milks_Infants_0-6_months_final.pdf (accessed May 2016)

5 British Specialist Nutrition Association Ltd. Legislation. Available at: www.bsna.co.uk/legislation/ (accessed June 2016)

6 Caffarelli C, Baldi F, Bendandi B et al (2010). Cows’ milk protein allergy in children: a practical guide. Italian Journal of Pediatrics; 36(5)

7 Vandenplas Y, Brueton M, Dupont C et al (2007). Guidelines for the diagnosis and management of cows’ milk protein allergy in infants. Archives of Disease in Childhood; 92(10): 902-908

8 National Institute for Health and Clinical Excellence (2015). Cows’ milk protein allergy in children. Available at: http://cks.nice.org.uk/cows-milk-protein-allergy-in-children (accessed May 2016)

9 Ludman S, Shah N and Fox A (2013). Managing cows' milk allergy in children (clinical review). British Medical Journal; 347: f5424

10 Lucassen PL, Assendelft WJ, Gubbels JW, et al (1998). Effectiveness of treatments for infantile colic: systematic review. British Medical Journal; 316: 1563-1569

11 MacDonald S (2015). Gastroenterology. In: Shaw V (Ed). Clinical Paediatric Dietetics (4th edition). Wiley Blackwell Publishing

12 Committee on Nutrition of the American Academy of Pediatrics (2006). Lactose intolerance in infants, children and adolescents. Pediatrics; 118: 1279-1286

13 Kukuruzovic R, Brewster D (2002). Milk formulas in acute gastroenteritis and malnutrition: a randomised trial. Journal of Paediatrics and Child Health; 38(6): 571-577

14 Lee KS, Lee JH (2012). Clinical applications and limitations of a special formula for diarrhea in children. Journal of the Korean Medical Association; 55: 551-561

15 Mendez M, Anthony M, Arab L (2002). Soy-based infant milks and infant growth and development: a review. The Journal of Nutrition; 132: 2127-2130

16 Agostoni C, Axelsson I, Goulet O et al (2006). Soy protein infant milk and follow-on infant milk: A commentary by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition; 42: 352-361

17 Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2003). Phytoestrogens and Health. Available at: http://cot.food.gov.uk/pdfs/phytoreport0503 (accessed May 2016)

18 MacDonald A, Portnoi P (2015). Disorders of Carbohydrate Metabolism: Galactosaemia. In: Shaw V (Ed). Clinical Paediatric Dietetics (4th edition). Wiley Blackwell Publishing

19 King C, Tavener K (2015). Preterm Infants. In: Shaw V (Ed). Clinical Paediatric Dietetics (4th edition). Wiley Blackwell Publishing

20 Koletzko B, Poindexter B, Uauy R (Eds) (2014). Nutritional Care of Preterm Infants: Scientific Basis and Practical Guidelines. World Rev Nutr Diet. Basel, Karger; vol 110: 4-10

21 Agostoni C, Buonocore G, Carnielli VP, et al (2010). Enteral Nutrition Supply for Preterm Infants: Commentary from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Committee (ESPGHAN). Journal of Paediatric Gastroenterology and Nutrition; 50, 1-9

22 Tsang RC, Lucas A, Uauy R, Zlotkin S (2005). Nutritional needs of the preterm infant: scientific basis and practical guidelines. Baltimore: Williams & Wilkins

23 Aggett P, Agostoni C, Axelsson I et al (2006). Feeding preterm infants after hospital discharge. A commentary by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition; 42: 596-603

24 Young L, Morgan J, McCormick FM, McGuire W (2012). Nutrient-enriched infant milk versus standard term infant milk for preterm infants following hospital discharge. Cochrane Database of Systematic Reviews 2012, Issue 3.

25 Pearce J, Langley-Evans S (2013). The types of food introduced during complementary feeding and risk of childhood obesity: a systematic review. International Journal of Obesity; 37: 477-485

26 National Institute for Health and Care Excellence (2015). Gastro-oesophageal Reflux Disease: Recognition, Diagnosis and Management in Children and Young People. NICE Guideline. Available at: www.nice.org.uk/guidance/ng1/resources/gastrooesophageal-reflux-disease-recognition-diagnosis-and-management-in-children-and-young-people-51035086789 (accessed May 2016)

Page 41 - FATTY ACID SUPPLEMENTS AND SCHOOL PERFORMANCE

1 Fernstrom JD (2000). Can nutrient supplements modify brain function? Am J Clin Nutr 71: 1669S-73S

2 McNamara RK et al (2006). Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75: 329-349

3 O’Brien JS and Sampson EL (1965). Lipid composition of the normal human brain: grey matter, white matter, and myelin. Journal of Lipid Research 6: 537-544

4 Martins JG (2009). EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acids supplementation in depression: Evidence from a meta-analysis of randomised controlled trials. J Am Coll Nutr 28: 525-542

5 Calder PC and Yaqoob P (2010). Understanding omega-3 polyunsaturated fatty acids. Postgraduate Medicine 12: 148-157

6 Kuratko CN et al (2013). The relationship of docosahexaenoic acid (DHA) with learning and behaviour in healthy children: A review. Nutrients 5: 2777-2810

7 Ruxton C and Derbyshire E (2013). Fatty acids in the management of ADHD. Complete Nutrition 13: 85-87

8 Kirby A et al (2010). Children’s learning and behaviour and the association with cheek cell polyunsaturated fatty acid levels. Res Dev Disabil 31: 731-42

9 Frensham LJ et al (2012). Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behaviour: methodological considerations and implications for children and adolescents in developed societies. Nutr Rev 70: 594-610

10 Brew BK et al (2015). Omega-3 supplementation during the first five years of life and later academic performance: a randomised controlled trial. Eur J Clin Nutr 69: 419-24

11 Parletta N et al (2013). Effects of fish oil supplementation on learning and behaviour of children from Australian Indigenous remote community schools: a randomised controlled trial. Prostaglandins Leukot Essent Fatty Acids 89: 71-9

12 Osendarp S, Baghurst KI, Bryan J et al (2007). Effect of a 12-month micronutrient intervention on learning and memory in well-nourished and marginallynourished school-aged children, two parallel, randomised, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr 86: 1082-1093

13 Richardson AJ et al (2012). Docosahexaenoic acid for reading, cognition and behaviour in children aged 7-9 years: a randomised, controlled trial (the DOLAB Study). PLoS One 7: e43909

14 Tammam JD et al (2016). A randomised double-blind placebo-controlled trial investigating the behavioural effects of vitamin, mineral and n-3 fatty acid supplementation in typically developing adolescent schoolchildren. Br J Nutr 115: 361-73

15 Kirby A et al (2010). A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil 31: 718-30

16 Ryan AS and Nelson EB (2008). Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomised, placebo controlled, double-blind study. Clin Pediatr 47: 355-362

17 Baumgartner J et al (2012). Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: a randomised, double- blind, placebo-controlled intervention in South Africa. Am J Clin Nutr 96: 1327-38

18 Kennedy DO et al (2009). Cognitive and mood effects of eight weeks’ supplementation with 400mg or 1000mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr Neurosci 12: 48-56

19 Ruxton CHS (2011). The benefits of fish consumption. Nutr Bull 36: 6-19

20 Gibbs R (2012). Personal communication. Figures calculated from the National Diet and Nutrition Survey rolling programme 2008-11

21 Scientific Advisory Committee on Nutrition/Committee on Toxicology (2004). Advice on fish consumption: benefits and risks. TSO: London

PAGE 45 - PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS

1. Managing Adult Malnutrition in the Community pathway. http://malnutritionpathway.co.uk/downloads/Managing_Malnutrition.pdf (accessed 8 January 2016)

2. NHS England Guidance on Commissioning Excellent Nutrition and Hydration 2015-2018, www.england.nhs.uk/wp-content/uploads/2015/10/nut-hyd-guid.pdf (accessed 8 January 2016)

3. NICE Clinical Guideline [CG32], Nutrition Support for Adults: oral nutrition support, enteral tube feeding and parenteral nutrition. National Institute for Health and Care Excellence, 2006. Section 1, Footnote 11 www.nice.org.uk/guidance/cg32

4. NICE Clinical Guideline [CG32], ibid, Section 1.6.7

5. NICE Quality Standard [QS24] Nutrition support for adults. National Institute for Health and Care Excellence, 2012. www.nice.org.uk/guidance/qs24/chapter/Quality-statement-2-Treatment

6. Elia M. The cost of malnutrition in England and potential cost savings from nutritional interventions. Malnutrition Action Group of BAPEN and the National Institute for Health Research Southampton Biomedical Research Centre, 2015

7. Elia M. The cost of malnutrition in England, 2015. Ibid

8. NICE Cost Saving Guidance on Nutrition support in adults [QS24], 2012.

9. Elia, M et al. The cost of disease-related malnutrition in the UK and economic considerations for the use of oral nutritional supplements (ONS) in adults. Health Economic Report on Malnutrition in the UK. BAPEN: 2012, available here: http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports/the-cost-of-disease-related-malnutrition-in-the-uk

10. Elia M et al. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings. Clin Nutr 2016; 35 (1); 125-37.

11. Elia M et al. A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in the hospital setting. Clin Nutr 2016; 35 (2) 370-80.

12. http://www.bsna.co.uk/categories/medical_foods/

13. Weekes CE et al. A review of the evidence for the impact of improving nutritional care on nutritional and clinical outcomes and cost, Journal of Human Nutrition and Dietetics, 2009; 22 (4): 324–335.

14. Weekes CE et al. 2009, ibid

15. Elia, M et al. The cost of disease-related malnutrition in the UK and economic considerations for the use of oral nutritional supplements (ONS) in adults. Health Economic Report on Malnutrition in the UK. BAPEN: 2012, available here: http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports/the-cost-of-disease-related-malnutrition-in-the-uk